Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · CRYO CELL INTERNATIONAL INC (CCEL)

Cryo-Cell gets NYSE American plan acceptance, listing kept through September 9, 2027

Neutral Impact 3 of 5 legal/regulatory Written later

Cryo-Cell International received written notice on May 6, 2026 that NYSE Regulation accepted its plan to regain compliance with NYSE American continued listing standards. The company's common stock will keep trading on NYSE American during a plan period ending September 9, 2027, but the company says it cannot assure it will regain compliance by then, and NYSE American may begin delisting proceedings if it does not.

Key points

  • NYSE Regulation accepted the compliance plan the company submitted on April 8, 2026, and granted a plan period through September 9, 2027.
  • The deficiencies cited are a stockholders' deficit as of November 30, 2025, and net losses in two of the three most recent fiscal years.
  • Common stock continues to be listed and traded on NYSE American, subject to the plan's initiatives and periodic review.
  • If the company fails to regain compliance by the deadline or make progress under the plan, NYSE American may initiate delisting proceedings.

The filing

CompanyCRYO CELL INTERNATIONAL INC (CCEL)
Form8-K, current report
Filed with the SECMay 8, 2026, 4:00 PM ET
Accession number0001193125-26-214569

Items reported: 3.01 Delisting / Listing Rule Notice7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:28 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 08, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.